Argentina

Argentina

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.35 (0.30 - 0.40) 2019 Modelled IHME
0.35 (0.30 - 0.40) 2018 Modelled IHME
0.35 (0.30 - 0.41) 2017 Modelled IHME
0.35 (0.30 - 0.40) 2016 Modelled IHME
0.35 (0.30 - 0.41) 2015 Modelled IHME
0.35 (0.30 - 0.41) 2014 Modelled IHME
0.36 (0.30 - 0.41) 2013 Modelled IHME
0.37 (0.31 - 0.42) 2012 Modelled IHME
0.37 (0.31 - 0.43) 2011 Modelled IHME
0.38 (0.31 - 0.44) 2010 Modelled IHME
0.38 (0.32 - 0.44) 2009 Modelled IHME
0.38 (0.32 - 0.44) 2008 Modelled IHME
0.39 (0.32 - 0.45) 2007 Modelled IHME
0.39 (0.33 - 0.45) 2006 Modelled IHME
0.39 (0.33 - 0.46) 2005 Modelled IHME
0.39 (0.33 - 0.46) 2004 Modelled IHME
0.39 (0.33 - 0.46) 2003 Modelled IHME
0.39 (0.33 - 0.46) 2002 Modelled IHME
0.4 (0.33 - 0.46) 2001 Modelled IHME
0.4 (0.33 - 0.46) 2000 Modelled IHME
0.4 (0.33 - 0.47) 1999 Modelled IHME
0.4 (0.34 - 0.47) 1998 Modelled IHME
0.41 (0.34 - 0.47) 1997 Modelled IHME
0.41 (0.34 - 0.48) 1996 Modelled IHME
0.41 (0.34 - 0.49) 1995 Modelled IHME
0.41 (0.34 - 0.49) 1994 Modelled IHME
0.41 (0.34 - 0.49) 1993 Modelled IHME
0.41 (0.34 - 0.49) 1992 Modelled IHME
0.41 (0.34 - 0.49) 1991 Modelled IHME
0.41 (0.34 - 0.49) 1990 Modelled IHME
2.1 (1.40 - 2.80) 1999 Survey/reported Silveira TR et al, 1999
0.06 (0.05 - 0.09) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.02 (0.01 - 0.03) 2019 Modelled IHME
0.02 (0.01 - 0.03) 2018 Modelled IHME
0.02 (0.01 - 0.03) 2017 Modelled IHME
0.02 (0.01 - 0.03) 2016 Modelled IHME
0.02 (0.01 - 0.03) 2015 Modelled IHME
0.02 (0.01 - 0.03) 2014 Modelled IHME
0.02 (0.01 - 0.03) 2013 Modelled IHME
0.02 (0.01 - 0.03) 2012 Modelled IHME
0.02 (0.01 - 0.03) 2011 Modelled IHME
0.02 (0.01 - 0.03) 2010 Modelled IHME
0.02 (0.01 - 0.03) 2009 Modelled IHME
0.02 (0.01 - 0.03) 2008 Modelled IHME
0.03 (0.02 - 0.04) 2007 Modelled IHME
0.03 (0.02 - 0.04) 2006 Modelled IHME
0.03 (0.02 - 0.05) 2005 Modelled IHME
0.04 (0.02 - 0.05) 2004 Modelled IHME
0.04 (0.03 - 0.06) 2003 Modelled IHME
0.05 (0.03 - 0.07) 2002 Modelled IHME
0.06 (0.04 - 0.08) 2001 Modelled IHME
0.07 (0.05 - 0.09) 2000 Modelled IHME
0.08 (0.05 - 0.11) 1999 Modelled IHME
0.1 (0.07 - 0.14) 1998 Modelled IHME
0.12 (0.08 - 0.17) 1997 Modelled IHME
0.14 (0.09 - 0.20) 1996 Modelled IHME
0.15 (0.09 - 0.21) 1995 Modelled IHME
0.15 (0.09 - 0.21) 1994 Modelled IHME
0.15 (0.09 - 0.21) 1993 Modelled IHME
0.15 (0.09 - 0.21) 1992 Modelled IHME
0.15 (0.09 - 0.21) 1991 Modelled IHME
0.15 (0.09 - 0.21) 1990 Modelled IHME
0.01 (0.01 - 0.01) 2015 Modelled WHO
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.24 (1.67 - 2.99) 2019 Modelled IHME
2.26 (1.69 - 3.01) 2018 Modelled IHME
2.32 (1.73 - 3.08) 2017 Modelled IHME
2.35 (1.76 - 3.10) 2016 Modelled IHME
2.3 (1.71 - 3.01) 2015 Modelled IHME
2.29 (1.71 - 3) 2014 Modelled IHME
2.34 (1.75 - 3.07) 2013 Modelled IHME
2.37 (1.76 - 3.13) 2012 Modelled IHME
2.4 (1.80 - 3.15) 2011 Modelled IHME
2.43 (1.82 - 3.19) 2010 Modelled IHME
2.54 (1.90 - 3.32) 2009 Modelled IHME
2.72 (2.05 - 3.57) 2008 Modelled IHME
2.94 (2.20 - 3.84) 2007 Modelled IHME
2.98 (2.22 - 3.85) 2006 Modelled IHME
2.97 (2.22 - 3.87) 2005 Modelled IHME
2.95 (2.19 - 3.85) 2004 Modelled IHME
3 (2.24 - 3.90) 2003 Modelled IHME
2.96 (2.20 - 3.83) 2002 Modelled IHME
2.91 (2.16 - 3.77) 2001 Modelled IHME
2.89 (2.14 - 3.73) 2000 Modelled IHME
2.97 (2.19 - 3.83) 1999 Modelled IHME
2.98 (2.19 - 3.86) 1998 Modelled IHME
2.99 (2.19 - 3.86) 1997 Modelled IHME
2.98 (2.19 - 3.87) 1996 Modelled IHME
2.95 (2.18 - 3.80) 1995 Modelled IHME
2.95 (2.18 - 3.80) 1994 Modelled IHME
3.01 (2.22 - 3.89) 1993 Modelled IHME
3.07 (2.25 - 3.99) 1992 Modelled IHME
3.05 (2.23 - 3.98) 1991 Modelled IHME
3.08 (2.25 - 4.03) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
1,012 (755 - 1,348) 2019 Modelled IHME
1,013 (756 - 1,345) 2018 Modelled IHME
1,027 (767 - 1,368) 2017 Modelled IHME
1,032 (773 - 1,362) 2016 Modelled IHME
999 (744 - 1,308) 2015 Modelled IHME
985 (734 - 1,291) 2014 Modelled IHME
995 (742 - 1,304) 2013 Modelled IHME
997 (741 - 1,318) 2012 Modelled IHME
998 (747 - 1,312) 2011 Modelled IHME
1,001 (748 - 1,313) 2010 Modelled IHME
1,033 (772 - 1,349) 2009 Modelled IHME
1,093 (822 - 1,433) 2008 Modelled IHME
1,169 (874 - 1,525) 2007 Modelled IHME
1,169 (873 - 1,513) 2006 Modelled IHME
1,156 (861 - 1,504) 2005 Modelled IHME
1,135 (842 - 1,478) 2004 Modelled IHME
1,140 (849 - 1,484) 2003 Modelled IHME
1,114 (829 - 1,441) 2002 Modelled IHME
1,081 (803 - 1,403) 2001 Modelled IHME
1,063 (787 - 1,373) 2000 Modelled IHME
1,081 (798 - 1,393) 1999 Modelled IHME
1,076 (790 - 1,392) 1998 Modelled IHME
1,065 (781 - 1,377) 1997 Modelled IHME
1,052 (775 - 1,368) 1996 Modelled IHME
1,032 (764 - 1,330) 1995 Modelled IHME
1,021 (755 - 1,315) 1994 Modelled IHME
1,031 (760 - 1,333) 1993 Modelled IHME
1,042 (763 - 1,352) 1992 Modelled IHME
1,022 (747 - 1,334) 1991 Modelled IHME
1,019 (744 - 1,334) 1990 Modelled IHME
1,517 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
16 (11 - 23) 2019 Modelled IHME
16 (11 - 23) 2018 Modelled IHME
16 (11 - 23) 2017 Modelled IHME
16 (11 - 23) 2016 Modelled IHME
16 (11 - 23) 2015 Modelled IHME
16 (11 - 23) 2014 Modelled IHME
16 (11 - 23) 2013 Modelled IHME
17 (12 - 23) 2012 Modelled IHME
17 (12 - 24) 2011 Modelled IHME
17 (12 - 24) 2010 Modelled IHME
17 (12 - 24) 2009 Modelled IHME
17 (12 - 24) 2008 Modelled IHME
17 (12 - 25) 2007 Modelled IHME
18 (12 - 25) 2006 Modelled IHME
18 (12 - 25) 2005 Modelled IHME
18 (12 - 25) 2004 Modelled IHME
18 (12 - 25) 2003 Modelled IHME
18 (12 - 25) 2002 Modelled IHME
18 (12 - 25) 2001 Modelled IHME
18 (12 - 25) 2000 Modelled IHME
18 (12 - 25) 1999 Modelled IHME
18 (12 - 25) 1998 Modelled IHME
18 (12 - 25) 1997 Modelled IHME
17 (12 - 25) 1996 Modelled IHME
17 (12 - 25) 1995 Modelled IHME
17 (12 - 25) 1994 Modelled IHME
17 (12 - 25) 1993 Modelled IHME
17 (12 - 25) 1992 Modelled IHME
17 (12 - 25) 1991 Modelled IHME
17 (12 - 24) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
82 2018 Survey/reported WHO/UNICEF
80 2017 Survey/reported WHO/UNICEF
81 2016 Survey/reported WHO/UNICEF
84 2015 Survey/reported WHO/UNICEF
87 2014 Survey/reported WHO/UNICEF
85 2013 Survey/reported WHO/UNICEF
88 2012 Survey/reported WHO/UNICEF
85 2011 Survey/reported WHO/UNICEF
79 2010 Survey/reported WHO/UNICEF
81 2009 Survey/reported WHO/UNICEF
79 2008 Survey/reported WHO/UNICEF
76 2007 Survey/reported WHO/UNICEF
72 2006 Survey/reported WHO/UNICEF
71 2005 Survey/reported WHO/UNICEF
65 2004 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
86 2018 Survey/reported WHO/UNICEF
86 2017 Survey/reported WHO/UNICEF
92 2016 Survey/reported WHO/UNICEF
94 2015 Survey/reported WHO/UNICEF
94 2014 Survey/reported WHO/UNICEF
94 2013 Survey/reported WHO/UNICEF
91 2012 Survey/reported WHO/UNICEF
91 2011 Survey/reported WHO/UNICEF
94 2010 Survey/reported WHO/UNICEF
94 2009 Survey/reported WHO/UNICEF
90 2008 Survey/reported WHO/UNICEF
85 2007 Survey/reported WHO/UNICEF
84 2006 Survey/reported WHO/UNICEF
88 2005 Survey/reported WHO/UNICEF
81 2004 Survey/reported WHO/UNICEF
73 2003 Survey/reported WHO/UNICEF
66 2002 Survey/reported WHO/UNICEF
Showing out of
Show more
HBV National Action Plan
HBV elimination goal
Year of HBV elimination goal
2030
HBV testing policy
Pregnant women
HepB birth dose policy
Yes
Year of birth dose introduction
2000
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
HCV testing policy
No policy
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.5 (0.40 - 0.60) 2019 Modelled IHME
0.5 (0.41 - 0.60) 2018 Modelled IHME
0.49 (0.40 - 0.60) 2017 Modelled IHME
0.49 (0.40 - 0.60) 2016 Modelled IHME
0.48 (0.39 - 0.59) 2015 Modelled IHME
0.46 (0.38 - 0.57) 2014 Modelled IHME
0.44 (0.36 - 0.54) 2013 Modelled IHME
0.42 (0.34 - 0.51) 2012 Modelled IHME
0.39 (0.32 - 0.48) 2011 Modelled IHME
0.38 (0.30 - 0.46) 2010 Modelled IHME
0.37 (0.30 - 0.45) 2009 Modelled IHME
0.36 (0.29 - 0.43) 2008 Modelled IHME
0.35 (0.29 - 0.42) 2007 Modelled IHME
0.35 (0.29 - 0.41) 2006 Modelled IHME
0.34 (0.28 - 0.41) 2005 Modelled IHME
0.34 (0.28 - 0.40) 2004 Modelled IHME
0.33 (0.27 - 0.40) 2003 Modelled IHME
0.33 (0.27 - 0.40) 2002 Modelled IHME
0.33 (0.27 - 0.40) 2001 Modelled IHME
0.33 (0.27 - 0.40) 2000 Modelled IHME
0.33 (0.27 - 0.40) 1999 Modelled IHME
0.33 (0.27 - 0.40) 1998 Modelled IHME
0.33 (0.27 - 0.40) 1997 Modelled IHME
0.33 (0.27 - 0.40) 1996 Modelled IHME
0.34 (0.28 - 0.41) 1995 Modelled IHME
0.35 (0.28 - 0.41) 1994 Modelled IHME
0.36 (0.30 - 0.43) 1993 Modelled IHME
0.38 (0.32 - 0.46) 1992 Modelled IHME
0.41 (0.34 - 0.49) 1991 Modelled IHME
0.44 (0.36 - 0.53) 1990 Modelled IHME
Showing out of
Show more

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
1.5 (0.50 - 2.50) 2014 Modelled Gower et al, 2014
People who inject drugs (PWID)
Download
Value (%) Year Type Source
54.6 (51.10 - 58.10) 2001 Survey/reported Weissenbacher M et al, 2003

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
7.82 (6.26 - 9.59) 2019 Modelled IHME
7.79 (6.22 - 9.55) 2018 Modelled IHME
7.87 (6.27 - 9.72) 2017 Modelled IHME
7.86 (6.25 - 9.68) 2016 Modelled IHME
7.51 (6.01 - 9.26) 2015 Modelled IHME
7.31 (5.81 - 8.96) 2014 Modelled IHME
7.26 (5.82 - 8.92) 2013 Modelled IHME
7.14 (5.70 - 8.81) 2012 Modelled IHME
6.99 (5.53 - 8.68) 2011 Modelled IHME
6.83 (5.36 - 8.47) 2010 Modelled IHME
6.68 (5.28 - 8.25) 2009 Modelled IHME
6.56 (5.19 - 8.13) 2008 Modelled IHME
6.54 (5.18 - 8.07) 2007 Modelled IHME
6.21 (4.94 - 7.67) 2006 Modelled IHME
6.06 (4.80 - 7.51) 2005 Modelled IHME
6.04 (4.81 - 7.46) 2004 Modelled IHME
6.17 (4.92 - 7.63) 2003 Modelled IHME
6.13 (4.90 - 7.63) 2002 Modelled IHME
6.05 (4.83 - 7.50) 2001 Modelled IHME
6.01 (4.79 - 7.50) 2000 Modelled IHME
6.16 (4.89 - 7.67) 1999 Modelled IHME
6.18 (4.88 - 7.70) 1998 Modelled IHME
6.15 (4.82 - 7.70) 1997 Modelled IHME
6.1 (4.77 - 7.62) 1996 Modelled IHME
6.03 (4.72 - 7.55) 1995 Modelled IHME
6.03 (4.70 - 7.55) 1994 Modelled IHME
6.18 (4.85 - 7.76) 1993 Modelled IHME
6.35 (4.97 - 7.94) 1992 Modelled IHME
6.36 (4.94 - 7.94) 1991 Modelled IHME
6.5 (5.04 - 8.16) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
3,527 (2,823 - 4,327) 2019 Modelled IHME
3,484 (2,783 - 4,275) 2018 Modelled IHME
3,489 (2,780 - 4,313) 2017 Modelled IHME
3,451 (2,745 - 4,253) 2016 Modelled IHME
3,266 (2,612 - 4,024) 2015 Modelled IHME
3,142 (2,500 - 3,851) 2014 Modelled IHME
3,089 (2,473 - 3,792) 2013 Modelled IHME
3,005 (2,399 - 3,704) 2012 Modelled IHME
2,907 (2,300 - 3,609) 2011 Modelled IHME
2,808 (2,204 - 3,483) 2010 Modelled IHME
2,716 (2,147 - 3,355) 2009 Modelled IHME
2,637 (2,084 - 3,266) 2008 Modelled IHME
2,597 (2,059 - 3,205) 2007 Modelled IHME
2,440 (1,940 - 3,016) 2006 Modelled IHME
2,356 (1,866 - 2,918) 2005 Modelled IHME
2,321 (1,847 - 2,868) 2004 Modelled IHME
2,343 (1,868 - 2,898) 2003 Modelled IHME
2,305 (1,840 - 2,869) 2002 Modelled IHME
2,248 (1,796 - 2,790) 2001 Modelled IHME
2,213 (1,761 - 2,760) 2000 Modelled IHME
2,245 (1,783 - 2,795) 1999 Modelled IHME
2,228 (1,758 - 2,775) 1998 Modelled IHME
2,195 (1,721 - 2,747) 1997 Modelled IHME
2,154 (1,687 - 2,694) 1996 Modelled IHME
2,108 (1,652 - 2,641) 1995 Modelled IHME
2,088 (1,628 - 2,614) 1994 Modelled IHME
2,120 (1,663 - 2,661) 1993 Modelled IHME
2,155 (1,685 - 2,694) 1992 Modelled IHME
2,133 (1,655 - 2,661) 1991 Modelled IHME
2,152 (1,670 - 2,701) 1990 Modelled IHME
1,599 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
36 (27 - 46) 2019 Modelled IHME
36 (27 - 46) 2018 Modelled IHME
36 (27 - 46) 2017 Modelled IHME
36 (27 - 46) 2016 Modelled IHME
36 (27 - 46) 2015 Modelled IHME
36 (27 - 45) 2014 Modelled IHME
36 (27 - 45) 2013 Modelled IHME
36 (27 - 46) 2012 Modelled IHME
36 (27 - 46) 2011 Modelled IHME
36 (27 - 46) 2010 Modelled IHME
36 (27 - 46) 2009 Modelled IHME
36 (27 - 46) 2008 Modelled IHME
36 (27 - 46) 2007 Modelled IHME
36 (27 - 46) 2006 Modelled IHME
36 (26 - 46) 2005 Modelled IHME
36 (27 - 46) 2004 Modelled IHME
36 (27 - 45) 2003 Modelled IHME
36 (26 - 45) 2002 Modelled IHME
36 (26 - 45) 2001 Modelled IHME
36 (26 - 45) 2000 Modelled IHME
35 (26 - 45) 1999 Modelled IHME
35 (26 - 44) 1998 Modelled IHME
35 (26 - 44) 1997 Modelled IHME
35 (25 - 44) 1996 Modelled IHME
34 (25 - 44) 1995 Modelled IHME
34 (25 - 43) 1994 Modelled IHME
34 (25 - 43) 1993 Modelled IHME
34 (25 - 43) 1992 Modelled IHME
34 (25 - 44) 1991 Modelled IHME
34 (25 - 44) 1990 Modelled IHME
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
Year of HBV elimination goal
2030
HBV testing policy
Pregnant women
HepB birth dose policy
Yes
Year of birth dose introduction
2000
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
HCV testing policy
No policy
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)

Overview

HBV elimination goal
Year of goal
2030
HCV elimination goal
Year of goal
2030

Hepatitis related deaths (national)

Modelled

HBV
1,012
2019
(755 - 1,348)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
3,527
2019
(2,823 - 4,327)
IHME

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
82 (%)
2018
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines